TY - JOUR
T1 - Interaction landscape of inherited polymorphisms with somatic events in cancer
AU - Carter, Hannah
AU - Marty, Rachel
AU - Hofree, Matan
AU - Gross, Andrew M.
AU - Jensen, James
AU - Fisch, Kathleen M.
AU - Wu, Xingyu
AU - Deboever, Christopher
AU - Van Nostrand, Eric L.
AU - Song, Yan
AU - Wheeler, Emily
AU - Kreisberg, Jason F.
AU - Lippman, Scott M.
AU - Yeo, Gene W.
AU - Gutkind, J. Silvio
AU - Ideker, Trey
N1 - Publisher Copyright:
© 2017 American Association for Cancer Research.
PY - 2017/4
Y1 - 2017/4
N2 - Recent studies have characterized the extensive somatic alterations that arise during cancer. However, the somatic evolution of a tumor may be significantly affected by inherited polymorphisms carried in the germline. Here, we analyze genomic data for 5,954 tumors to reveal and systematically validate 412 genetic interactions between germline polymorphisms and major somatic events, including tumor formation in specific tissues and alteration of specific cancer genes. Among germline–somatic interactions, we found germline variants in RBFOX1 that increased incidence of SF3B1 somatic mutation by 8-fold via functional alterations in RNA splicing. Similarly, 19p13.3 variants were associated with a 4-fold increased likelihood of somatic mutations in PTEN. In support of this association, we found that PTEN knockdown sensitizes the MTOR pathway to high expression of the 19p13.3 gene GNA11. Finally, we observed that stratifying patients by germline polymorphisms exposed distinct somatic mutation landscapes, implicating new cancer genes. This study creates a validated resource of inherited variants that govern where and how cancer develops, opening avenues for prevention research.
AB - Recent studies have characterized the extensive somatic alterations that arise during cancer. However, the somatic evolution of a tumor may be significantly affected by inherited polymorphisms carried in the germline. Here, we analyze genomic data for 5,954 tumors to reveal and systematically validate 412 genetic interactions between germline polymorphisms and major somatic events, including tumor formation in specific tissues and alteration of specific cancer genes. Among germline–somatic interactions, we found germline variants in RBFOX1 that increased incidence of SF3B1 somatic mutation by 8-fold via functional alterations in RNA splicing. Similarly, 19p13.3 variants were associated with a 4-fold increased likelihood of somatic mutations in PTEN. In support of this association, we found that PTEN knockdown sensitizes the MTOR pathway to high expression of the 19p13.3 gene GNA11. Finally, we observed that stratifying patients by germline polymorphisms exposed distinct somatic mutation landscapes, implicating new cancer genes. This study creates a validated resource of inherited variants that govern where and how cancer develops, opening avenues for prevention research.
UR - http://www.scopus.com/inward/record.url?scp=85016324008&partnerID=8YFLogxK
U2 - 10.1158/2159-8290.CD-16-1045
DO - 10.1158/2159-8290.CD-16-1045
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 28188128
AN - SCOPUS:85016324008
SN - 2159-8274
VL - 7
SP - 410
EP - 423
JO - Cancer Discovery
JF - Cancer Discovery
IS - 4
ER -